{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:48:48Z","timestamp":1792194528235,"version":"4.4.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Liver metastasis is present in a wide range of malignancies, with colorectal cancer as the most common site. Several minimally invasive treatments have been suggested for managing hepatic metastases, and cryoablation is among them, yet not widely used. In this systematic review, we aimed to assess the effectiveness of percutaneous cryoablation in all types of liver metastases.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A systematic search was performed in international databases, including PubMed, Scopus, Embase, and Web of Science, to find relevant studies reporting outcomes for percutaneous cryoablation in liver metastasis patients. In addition to baseline features such as mean age, gender, metastasis origin, and procedure details, procedure outcomes, including overall survival, local recurrence, quality of life (QoL), and complications, were extracted from the studies. Random-effect meta-analysis was performed to calculate the mean difference (MD) and 95% confidence interval for comparison of QoL.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We screened 2131 articles. Fifteen studies on 692 patients were included. Mean overall survival ranged from 14.5\u201329 months. The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value &lt;0.01) but increased one month (5.69 [3.99, 7.39], p-value &lt;0.01) and three months (3.75 [2.25, 5.24], p-value &lt;0.01) after the procedure.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Cryoablation is an effective procedure for the treatment of liver metastases, especially in cases that are poor candidates for liver resection. It could significantly improve QoL with favorable local recurrence.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0289975","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:38:36Z","timestamp":1692207516000},"page":"e0289975","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"18","author":[{"given":"Shaghayegh","family":"Khanmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Behnoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-3801","authenticated-orcid":true,"given":"Shahram","family":"Akhlaghpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"issue":"1","key":"pone.0289975.ref001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"D.I. Tsilimigras","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0289975.ref002","doi-asserted-by":"crossref","first-page":"101760","DOI":"10.1016\/j.canep.2020.101760","article-title":"Epidemiology of liver metastases","volume":"67","author":"S.R. Horn","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"pone.0289975.ref003","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.suronc.2012.11.002","article-title":"A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases","volume":"22","author":"A.A. Slesser","year":"2013","journal-title":"Surg Oncol"},{"issue":"3","key":"pone.0289975.ref004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11864-014-0297-1","article-title":"Liver-directed treatments for metastatic colorectal cancer","volume":"15","author":"M.A. Choti","year":"2014","journal-title":"Curr Treat Options Oncol"},{"issue":"12","key":"pone.0289975.ref005","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"B. Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"pone.0289975.ref006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/02656736.2016.1155758","article-title":"Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: Preliminary results and literature review","volume":"32","author":"F. Zhou","year":"2016","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"pone.0289975.ref007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0960-7404(99)00023-7","article-title":"Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer","volume":"8","author":"O.F. Bathe","year":"1999","journal-title":"Surg Oncol"},{"issue":"9","key":"pone.0289975.ref008","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.clon.2010.08.004","article-title":"Radiofrequency ablation in the treatment of breast cancer liver metastases","volume":"22","author":"R. Illing","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"pone.0289975.ref009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000449346","article-title":"Hepatocellular Carcinoma: The Role of Interventional Oncology","volume":"6","author":"M. Donadon","year":"2016","journal-title":"Liver Cancer"},{"key":"pone.0289975.ref010","article-title":"Cryoablation for the Palliation of Painful Bone Metastasis: A Systematic Review","author":"S. Khanmohammadi","year":"2023","journal-title":"CardioVascular and Interventional Radiology"},{"key":"pone.0289975.ref011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.bioeng.2.1.157","article-title":"Cryosurgery","volume":"2","author":"B. Rubinsky","year":"2000","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"pone.0289975.ref012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13244-019-0727-5","article-title":"Cryoablation and immunotherapy: an overview of evidence on its synergy","volume":"10","author":"B.M. Aarts","year":"2019","journal-title":"Insights Imaging"},{"issue":"3","key":"pone.0289975.ref013","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.crad.2013.09.014","article-title":"Percutaneous cryoablation of liver metastases from breast cancer: initial experience in 17 patients","volume":"69","author":"W. Zhang","year":"2014","journal-title":"Clin Radiol"},{"key":"pone.0289975.ref014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cryobiol.2019.01.011","article-title":"CT-guided percutaneous cryoablation combined with systemic chemotherapy for liver metastases from esophageal carcinoma: Initial experience","volume":"87","author":"Y. Wang","year":"2019","journal-title":"Cryobiology"},{"key":"pone.0289975.ref015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cryobiol.2018.04.010","article-title":"CT-guided percutaneous cryoablation for palliative therapy of gastric cancer liver metastases","volume":"82","author":"X. Chang","year":"2018","journal-title":"Cryobiology"},{"issue":"7","key":"pone.0289975.ref016","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D. Moher","year":"2009","journal-title":"PLoS Med"},{"key":"pone.0289975.ref017","unstructured":"NIH. Study Quality Assessment Tools. 2021 July, 2021 [cited 2022 September 9]; https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"7414","key":"pone.0289975.ref018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"J.P. Higgins","year":"2003","journal-title":"Bmj"},{"issue":"7","key":"pone.0289975.ref019","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1177\/21925682221110527","article-title":"Fixed-Effect vs Random-Effects Models for Meta-Analysis: 3 Points to Consider","volume":"12","author":"J.R. Dettori","year":"2022","journal-title":"Global Spine Journal"},{"issue":"12","key":"pone.0289975.ref020","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archsurg.137.12.1332","article-title":"A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies","volume":"137","author":"R. Adam","year":"2002","journal-title":"Archives of Surgery"},{"issue":"6","key":"pone.0289975.ref021","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jvir.2012.02.013","article-title":"Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: Initial survival, local control, and cost observations","volume":"23","author":"H.J. Bang","year":"2012","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"6","key":"pone.0289975.ref022","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/13645709809152902","article-title":"Cryoablation of hepatic neoplasia","volume":"7","author":"G. Feifel","year":"1998","journal-title":"Minimally Invasive Therapy & Allied Technologies"},{"issue":"5","key":"pone.0289975.ref023","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/IGC.0000000000000420","article-title":"Percutaneous cryoablation of ovarian cancer metastasis to the liver: initial experience in 13 patients","volume":"25","author":"W. Gao","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"pone.0289975.ref024","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2214\/AJR.16.17582","article-title":"Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes","volume":"209","author":"D.I. Glazer","year":"2017","journal-title":"American Journal of Roentgenology"},{"issue":"4","key":"pone.0289975.ref025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00261-016-0687-x","article-title":"Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series","volume":"41","author":"P.J. Littrup","year":"2016","journal-title":"Abdom Radiol (NY)"},{"issue":"8","key":"pone.0289975.ref026","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/110241501753171227","article-title":"Magnetic-resonance-guided percutaneous cryoablation of hepatic tumours","volume":"167","author":"T. Mala","year":"2001","journal-title":"Eur J Surg"},{"issue":"9","key":"pone.0289975.ref027","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1046\/j.1365-2168.1998.00839.x","article-title":"Preliminary experience with percutaneous cryotherapy of liver tumours","volume":"85","author":"G. Sch\u00fcder","year":"1998","journal-title":"British Journal of Surgery"},{"issue":"9","key":"pone.0289975.ref028","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3748\/wjg.14.1430","article-title":"Percutaneous cryosurgery for the treatment of hepatic colorectal metastases","volume":"14","author":"K.C. Xu","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"pone.0289975.ref029","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2214\/ajr.183.3.1830707","article-title":"Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases","volume":"183","author":"S.G. Silverman","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"pone.0289975.ref030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14123018","article-title":"The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report","volume":"14","author":"C. Pusceddu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"pone.0289975.ref031","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.1007\/s13277-014-2374-2","article-title":"Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases","volume":"35","author":"Z. Li","year":"2014","journal-title":"Tumor Biology"},{"issue":"5 Supplement 2","key":"pone.0289975.ref032","first-page":"S15","article-title":"Accomplishments in 2008 in the management of curable metastatic colorectal cancer","volume":"3","author":"R. Adam","year":"2009","journal-title":"Gastrointest Cancer Res"},{"issue":"10","key":"pone.0289975.ref033","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)","volume":"23","author":"T. Ruers","year":"2012","journal-title":"Ann Oncol"},{"issue":"2","key":"pone.0289975.ref034","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1148\/radiol.14141568","article-title":"Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study","volume":"275","author":"K.D. Song","year":"2015","journal-title":"Radiology"},{"issue":"2","key":"pone.0289975.ref035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.10081634","article-title":"Principles of and advances in percutaneous ablation","volume":"258","author":"M. Ahmed","year":"2011","journal-title":"Radiology"},{"issue":"3","key":"pone.0289975.ref036","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1148\/radiol.2373041104","article-title":"Multipolar radiofrequency ablation of hepatic tumors: initial experience","volume":"237","author":"B.B. Frericks","year":"2005","journal-title":"Radiology"},{"issue":"3","key":"pone.0289975.ref037","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"M.S. Chen","year":"2006","journal-title":"Ann Surg"},{"issue":"49","key":"pone.0289975.ref038","doi-asserted-by":"crossref","first-page":"e2252","DOI":"10.1097\/MD.0000000000002252","article-title":"Cryoablation Versus Radiofrequency Ablation for Hepatic Malignancies: A Systematic Review and Literature-Based Analysis","volume":"94","author":"S. Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0289975.ref039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-199701000-00006","article-title":"Repeat hepatectomy for colorectal liver metastases","volume":"225","author":"R. Adam","year":"1997","journal-title":"Annals of surgery"},{"issue":"3","key":"pone.0289975.ref040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrc3672","article-title":"Thermal ablation of tumours: biological mechanisms and advances in therapy","volume":"14","author":"K.F. Chu","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"pone.0289975.ref041","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.surg.2009.10.053","article-title":"Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model","volume":"147","author":"M.C. Jansen","year":"2010","journal-title":"Surgery"},{"issue":"22","key":"pone.0289975.ref042","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.3748\/wjg.v19.i22.3473","article-title":"Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer","volume":"19","author":"L.Z. Niu","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"47","key":"pone.0289975.ref043","doi-asserted-by":"crossref","first-page":"81967","DOI":"10.18632\/oncotarget.17804","article-title":"Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer","volume":"8","author":"M. Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"20","key":"pone.0289975.ref044","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011061","article-title":"The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances","volume":"22","author":"J.R. Janopaul-Naylor","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0289975.ref045","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1007\/s00330-015-3779-z","article-title":"Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Fronti\u00e8res meeting 2013","volume":"25","author":"A. Gillams","year":"2015","journal-title":"Eur Radiol"},{"key":"pone.0289975.ref046","doi-asserted-by":"crossref","first-page":"561669","DOI":"10.3389\/fonc.2020.561669","article-title":"Can Radiofrequency Ablation Replace Liver Resection for Solitary Colorectal Liver Metastasis? A Systemic Review and Meta-Analysis","volume":"10","author":"W. Hao","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"pone.0289975.ref047","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1111\/ans.13810","article-title":"Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma","volume":"88","author":"J. Liu","year":"2018","journal-title":"ANZ J Surg"},{"issue":"11","key":"pone.0289975.ref048","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s11605-014-2623-0","article-title":"Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer","volume":"18","author":"A. Andreou","year":"2014","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"pone.0289975.ref049","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11547-011-0697-2","article-title":"Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases","volume":"116","author":"G. Carrafiello","year":"2011","journal-title":"Radiol Med"},{"issue":"4","key":"pone.0289975.ref050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2214\/AJR.07.2198","article-title":"Radiofrequency ablation in the management of liver metastases from breast cancer","volume":"189","author":"C.T. Sofocleous","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"pone.0289975.ref051","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13651820701222677","article-title":"Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial","volume":"9","author":"D.A. Iannitti","year":"2007","journal-title":"HPB (Oxford)"},{"issue":"1","key":"pone.0289975.ref052","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2325\/jbcs.12.26","article-title":"Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer","volume":"12","author":"H. Abe","year":"2005","journal-title":"Breast Cancer"},{"issue":"5","key":"pone.0289975.ref053","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-0029-1246002","article-title":"Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients","volume":"32","author":"T. Lorentzen","year":"2011","journal-title":"Ultraschall Med"},{"issue":"2","key":"pone.0289975.ref054","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1148\/radiol.2332030454","article-title":"Breast cancer metastases in liver: laser-induced interstitial thermotherapy\u2014local tumor control rate and survival data","volume":"233","author":"M.G. Mack","year":"2004","journal-title":"Radiology"},{"issue":"2","key":"pone.0289975.ref055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/0008-5472.CAN-11-1782","article-title":"Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy","volume":"72","author":"R. Waitz","year":"2012","journal-title":"Cancer Res"},{"issue":"3","key":"pone.0289975.ref056","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"D.F. Cella","year":"1993","journal-title":"J Clin Oncol"},{"issue":"13\u201314","key":"pone.0289975.ref057","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/0959-8049(95)00296-0","article-title":"The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy","volume":"31a","author":"S. Kaasa","year":"1995","journal-title":"Eur J Cancer"},{"issue":"4","key":"pone.0289975.ref058","first-page":"296","article-title":"Quality of life and hepatocellular carcinoma","volume":"5","author":"S. Gandhi","year":"2014","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"pone.0289975.ref059","doi-asserted-by":"crossref","first-page":"e200101","DOI":"10.1148\/rycan.2021200101","article-title":"Cryoablation for Palliation of Painful Bone Metastases: The MOTION Multicenter Study","volume":"3","author":"J.W. Jennings","year":"2021","journal-title":"Radiol Imaging Cancer"},{"issue":"3","key":"pone.0289975.ref060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cncr.29743","article-title":"Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer","volume":"122","author":"A.A. Laviana","year":"2016","journal-title":"Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:39:17Z","timestamp":1692207557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289975"}},"subtitle":[],"editor":[{"given":"Ezio","family":"Lanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0289975","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}